Interviews

Dr Richard Snyder on the Impact of Novel, Costly Drugs on Prevalence of Value-Based Agreements
October 15, 2019 – 
Richard Snyder, MD, executive vice president of Facilitated Health Networks and chief medical officer at Independence Blue Cross, discusses how the increasing share of novel, costly therapies will impact the prevalence of value-based agreements.
Terrill Jordan Reflects on Practice Transformation Under OCM
October 11, 2019 – 
The main thing that the Oncology Care Model (OCM) has brought is a shift in the mindset, said Terrill Jordan, chief executive officer of Regional Cancer Care Associates.
Dr Lawrence Shulman Discusses the Role of Rising Drug Costs in Value-Based Care
October 06, 2019 – 
Lawrence N. Shulman, MD, director of the Center for Global Cancer Medicine at the Abramson Cancer Center, and professor of Medicine at the Hospital of the University of Pennsylvania, explains how providers are reacting to more effective, more costly therapies entering the cancer landscape.
Terrill Jordan Discusses OCM Performance Period 4 Results
October 01, 2019 – 
Terrill Jordan, chief executive officer of Regional Cancer Care Associates, discusses Oncology Care Model performance period 4 results and the biggest challenges community oncologists continue to face when trying to perform under the model.
Dr Michael Kolodziej Discusses Taking on 2-Sided Risk in OCM After PP4 Results
September 26, 2019 – 
Michael Kolodziej, MD, vice president and chief innovation officer at ADVI Health, Inc., discusses the move to 2-sided risk in the Oncology Care Model (OCM).
Dr Blase Polite Outlines the Decision to Move to 2-Sided Risk in the OCM
September 22, 2019 – 
CMS is trying to make a 2-sided risk model in the Oncology Care Model enticing for practices, but there is still a lot of math practices need to work out before making the decision, said Blase Polite, MD, associate professor of medicine and the executive director for accountable care at the University of Chicago.
Lani Alison Discusses How the OCM Allowed for Better Integration of Palliative Care
September 15, 2019 – 
Lani M. Alison, BSN, MS, HCQ, PCMH, CCE, vice president of Clinical Affairs, Regional Cancer Care Associates, explains how the implementation of the Oncology Care Model (OCM) allowed practices to better integrate palliative care.
Dr Iuliana Shapira Offers Examples of How Innovation Can Transform Cancer Care Delivery
September 10, 2019 – 
Innovation that transform cancer care delivery have to be multi-level, explained Iuliana Shapira, MD, chief medical officer, Regional Cancer Care Associates.
Lani Alison Outlines Questions Patients Have About Care Pathways, Treatment Guidelines
September 05, 2019 – 
Lani M. Alison, BSN, MS, HCQ, PCMH, CCE, vice president of Clinical Affairs, Regional Cancer Care Associates, explains the questions that patients have about oncology care pathways and treatment guidelines.
Dr Iuliana Shapira on Managing High Costs of Immuno-Oncology Drugs in Value-Based Care
August 28, 2019 – 
Iuliana Shapira, MD, chief medical officer, Regional Cancer Care Associates (RCCA), discusses how RCCA is managing the higher costs of immuno-oncology drugs in value-based care.
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.